Elwood V. Jensen: Gem of Research Industry

.

Elwood V. Jensen: Gem of Research Industry

Elwood V. Jensen has been accredited as such a medical researcher whose treatments for breast cancer have saved a number of lives. It was in 2004 that he was honored with the Albert Lasker Basic Medical Research Award.

The award is considered to be one of the respected awards in the field of science across the globe. Jensen started his research as a career in 1950s at the University of Chicago. His interest area was steroid hormones and with the help of the same, Jensen has been able to come up with such breast cancer treatments that hundreds of thousands of lives have been saved.

A lot of suspicion was there around steroid hormones, but it was the determination of Jensen, who proved that steroid hormones can be effective. It was in 1968 that Jensen came with a test for assessing the presence of estrogen receptors in breast cancer cells.

After coming with a test, Jensen said that breast cancers, which have been positive for estrogen, can be treated with medications like Tamoxifen. Not only this, he suggested some other options as well, like removal of ovaries to inhibit the estrogen hormone. With passage of time, his advancements in the area kept on increasing.


Latest News

Official manufacturing Index of China Moves Up
Walmart Wage Hike to Create a Ripple in the Other Industries
NXP Semiconductors to buy Smaller Peer Freescale Semiconductor
Minimum Wage for Tipped Workers Raised in New York
Office Depot and Home Depot Reports Better Than Expected Earnings Results
Attorney General Eric Schneiderman investigating the Selection Process of Casino
Barack Obama Calls for Stricter Standards for Brokers Advising on Saving Plans
Chefs of SoDel Concepts Restaurants Turn Girl Scout Cookies into Innovative Dess
Valeant Pharmaceuticals International Inc. to Acquire Salix Pharmaceuticals Ltd
Investors will be All Ears to Janet Yellen as she Testifies before the US Senate
Proposed Merger of Sysco and US Foods faces Strong Opposition
Procter & Gamble to Discontinue About Hundred of Its Brands by Summer